Literature DB >> 17591934

Improved real-time multiplex polymerase chain reaction detection of methylenetetrahydrofolate reductase (MTHFR) 677C>T and 1298A>C polymorphisms using nearest neighbor model-based probe design.

Raghunath P Agarwal1, Stephen M Peters, Manijeh Shemirani, Nicolas von Ahsen.   

Abstract

The disorders of folate metabolism caused by methylenetetrahydrofolate reductase (MTHFR) gene polymorphisms may lead to several disease states including coronary heart disease, venous thrombosis, and several types of cancer. We have developed a real-time multiplex single-tube polymerase chain reaction procedure on the LightCycler for the detection of the two most commonly occurring variants, 677C>T and 1298A>C, in the MTHFR gene. An improved probe design, based on the nearest neighbor model for nucleic acid-probe duplex stability, resulted in a better separation (DeltaTm approximately 10 degrees C) of melting peaks of the wild-type and mutant alleles than that by the existing method (DeltaTm approximately 3 degrees C) for specimens heterozygous for the 1298A>C polymorphism. Of the 333 blood specimens analyzed by this procedure, we did not find any samples that gave ambiguous results. The specimens with homozygous mutation for one polymorphism were of the wild type for the other variant. The assay was validated by the comparison of the genotyping results of 50 blood specimens from the LightCycler polymerase chain reaction with the conventional restriction fragment length polymorphism procedures. There was 100% concordance of the test results obtained by the two techniques. This assay is reliable, economical, and can be performed by less trained technologists compared with the procedure performed by the conventional restriction fragment length polymorphism technique.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17591934      PMCID: PMC1899423          DOI: 10.2353/jmoldx.2007.060035

Source DB:  PubMed          Journal:  J Mol Diagn        ISSN: 1525-1578            Impact factor:   5.568


  25 in total

1.  Differing effects of methylenetetrahydrofolate reductase single nucleotide polymorphisms on methotrexate efficacy and toxicity in rheumatoid arthritis.

Authors:  William E Evans
Journal:  Pharmacogenetics       Date:  2002-04

2.  C677T and A1298C polymorphisms of the methylenetetrahydrofolate reductase gene: incidence and effect of combined genotypes on plasma fasting and post-methionine load homocysteine in vascular disease.

Authors:  N Q Hanson; O Aras ; F Yang; M Y Tsai
Journal:  Clin Chem       Date:  2001-04       Impact factor: 8.327

3.  Use of two reporter dyes without interference in a single-tube rapid-cycle PCR: alpha(1)-antitrypsin genotyping by multiplex real-time fluorescence PCR with the LightCycler.

Authors:  N von Ahsen; M Oellerich; E Schütz
Journal:  Clin Chem       Date:  2000-02       Impact factor: 8.327

4.  Simultaneous detection of methylenetetrahydrofolate reductase gene polymorphisms, C677T and A1298C, by melting curve analysis with LightCycler.

Authors:  Sakurako Nakamura; Tsutomu Aoshima; Mayumi Ikeda; Yoshitaka Sekido; Kaoru Shimokata; Toshimitsu Niwa
Journal:  Anal Biochem       Date:  2002-07-15       Impact factor: 3.365

5.  Methylenetetrahydrofolate reductase polymorphisms increase risk of esophageal squamous cell carcinoma in a Chinese population.

Authors:  C Song; D Xing; W Tan; Q Wei; D Lin
Journal:  Cancer Res       Date:  2001-04-15       Impact factor: 12.701

6.  Pharmacogenetics of methotrexate: toxicity among marrow transplantation patients varies with the methylenetetrahydrofolate reductase C677T polymorphism.

Authors:  C M Ulrich; Y Yasui; R Storb; M M Schubert; J L Wagner; J Bigler; K S Ariail; C L Keener; S Li; H Liu; F M Farin; J D Potter
Journal:  Blood       Date:  2001-07-01       Impact factor: 22.113

7.  Identification of six methylenetetrahydrofolate reductase (MTHFR) genotypes resulting from common polymorphisms: impact on plasma homocysteine levels and development of coronary artery disease.

Authors:  C Meisel; I Cascorbi; T Gerloff; V Stangl; M Laule; J M Müller; K D Wernecke; G Baumann; I Roots; K Stangl
Journal:  Atherosclerosis       Date:  2001-02-15       Impact factor: 5.162

8.  The 1298A-->C polymorphism in methylenetetrahydrofolate reductase (MTHFR): in vitro expression and association with homocysteine.

Authors:  I S Weisberg; P F Jacques; J Selhub; A G Bostom; Z Chen; R Curtis Ellison; J H Eckfeldt; R Rozen
Journal:  Atherosclerosis       Date:  2001-06       Impact factor: 5.162

9.  Polymorphisms of 5,10-methylenetetrahydrofolate reductase and risk of gastric cancer in a Chinese population: a case-control study.

Authors:  H Shen; Y Xu; Y Zheng; Y Qian; R Yu; Y Qin; X Wang; M R Spitz; Q Wei
Journal:  Int J Cancer       Date:  2001-09-20       Impact factor: 7.396

10.  Methylenetetrahydrofolate reductase (MTHFR) polymorphism increases the risk of cervical intraepithelial neoplasia.

Authors:  C J Piyathilake; M Macaluso; G L Johanning; M Whiteside; D C Heimburger; A Giuliano
Journal:  Anticancer Res       Date:  2000 May-Jun       Impact factor: 2.480

View more
  1 in total

1.  A novel multiplex PCR-RFLP method for simultaneous detection of the MTHFR 677 C > T, eNOS +894 G > T and - eNOS -786 T > C variants among Malaysian Malays.

Authors:  Keat Wei Loo; Lyn Robyn Griffiths; Siew Hua Gan
Journal:  BMC Med Genet       Date:  2012-05-17       Impact factor: 2.103

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.